Project description
Biocompatible nanomedicines for cancer
Nanoparticles are emerging as a powerful tool in cancer immunotherapy, offering precise delivery and enhanced efficacy of treatments. These tiny particles can be engineered to carry various therapeutic agents directly to cancer cells, minimising damage to healthy tissues. Funded by the Marie Skłodowska-Curie Actions programme, the ChiralBoost project focuses on carbon dots (CDs) as agents for immunotherapy, given their good biocompatibility. Researchers will functionalise CDs with tumour antigens and immune adjuvants and study their effect on primary immune cell maturation. Project results on CDs could expand their utilisation beyond cancer treatment for broader biomedical applications.
Objective
Cancer immunotherapy is considered an effective cancer treatment strategy. However, there are still some obstacles, including the unresponsive state of the immune system to tumor antigen stimulation. In the last years, researchers have found that nanomaterials can modulate the immune system. Among many excellent nanomaterials, carbon-based nanomaterials stand out due to their good biocompatibility. Compared to the rich research on carbon nanotubes and graphene oxide, the research on carbon dots (CDs) in immunotherapy is still in its infancy. In ChiralBoost, we intend to explore the application of chiral carbon dots (Ch-CDs) in cancer immunotherapy. Ch-CDs will be synthesized by hydrothermal and microwave methods using protected L/D-tyrosine and L/D-tryptophan as precursors. Then, a tumor antigen model ovalbumin peptide and the immune adjuvant monophosphoryl lipid A will be grafted onto the Ch-CDs through post-functionalization. Next, the interaction and the immune response of the Ch-CDs on primary immune cells in vitro and in vivo, such as the ability to accelerate dendritic cell maturation and the ability to stimulate cytokine production will be explored. The generated results will open the way to explore the potential of Ch-CDs in cancer immunotherapy The conduct of this project is not only expected to the development of Ch-CDs-based anticancer nanomedicines but will also pave the way for biomedical applications of chiral nanomaterials in other potential clinical applications. The assembled research team is totally capable of achieving the ambitious objectives of the proposed project. The researcher, Dr. Hu, is a multidisciplinary researcher specializing in diverse carbon nanomaterials. The main supervisor (Dr. Alberto Bianco, Institute of Molecular and Cell Biology, CNRS) is among the pioneers of biomedical carbon-nanomaterials research, and the secondment co-supervisor (Prof. Sara Bals, University of Antwerp) is a renowned expert on microscopic techniques.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- engineering and technology nanotechnology nano-materials two-dimensional nanostructures graphene
- medical and health sciences medical biotechnology nanomedicine
- medical and health sciences clinical medicine oncology
- medical and health sciences basic medicine immunology immunotherapy
- medical and health sciences medical biotechnology tissue engineering bioartificial liver
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-MSCA-2023-PF-01
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
75794 PARIS
France
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.